Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fabbri

Showing results (351-360 of 370) with videos related to

Pageof 37
Sort By:
Journal of Endocrinological Investigation|June 24, 2015
Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1S Nuovo, M Passeri, E Di Benedetto, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 13, 2007
Prevalence of obesity in 6- and 9-year-old children living in Central-North Italy. Analysis of determinants and indicators of risk of overweightA Albertini, A Tripodi, A Fabbri, et al.
Physics in Medicine and Biology|September 25, 2025
Experimental characterization of a diamond detection system for combined dose, LET and RBE assessment in clinical proton beamsC Verona, A Fabbri, A Fazzi, et al.
British Journal of Cancer|November 27, 2001
SYT-SSX fusion genes and prognosis in synovial sarcomaA Mezzelani, L Mariani, E Tamborini, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO)C Tibaldi, S Ricci, F Russo, et al.
Journal of Endocrinological Investigation|December 4, 2009
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadismA Lenzi, G Balercia, A Bellastella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 23, 2021
Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On studyF Nelli, A Fabbri, A Onorato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2012
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)P L Zinzani, E Derenzini, C Pellegrini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2021
Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On studyF Nelli, A Fabbri, A Onorato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2022
Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third studyF Nelli, D Giannarelli, A Fabbri, et al.
Pageof 37

Showing results (351-360 of 370) with videos related to

Sort By:
Pageof 37
Journal of Endocrinological Investigation|June 24, 2015
Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1S Nuovo, M Passeri, E Di Benedetto, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 13, 2007
Prevalence of obesity in 6- and 9-year-old children living in Central-North Italy. Analysis of determinants and indicators of risk of overweightA Albertini, A Tripodi, A Fabbri, et al.
Physics in Medicine and Biology|September 25, 2025
Experimental characterization of a diamond detection system for combined dose, LET and RBE assessment in clinical proton beamsC Verona, A Fabbri, A Fazzi, et al.
British Journal of Cancer|November 27, 2001
SYT-SSX fusion genes and prognosis in synovial sarcomaA Mezzelani, L Mariani, E Tamborini, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO)C Tibaldi, S Ricci, F Russo, et al.
Journal of Endocrinological Investigation|December 4, 2009
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadismA Lenzi, G Balercia, A Bellastella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 23, 2021
Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On studyF Nelli, A Fabbri, A Onorato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2012
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)P L Zinzani, E Derenzini, C Pellegrini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2021
Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On studyF Nelli, A Fabbri, A Onorato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2022
Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third studyF Nelli, D Giannarelli, A Fabbri, et al.
Pageof 37